Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports
Viral Immunology · 2024
DOI: 10.1089/vim.2024.0034 ↗Kurz gefasst
Fallbericht in der Zeitschrift Viral Immunology, 2024. Verfasst von Abraham M Enyeji und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Community Medicine, Mercer University School of Medicine, Columbus, Georgia, 31901, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Azithromycin, COVID-19, COVID-19 Drug Treatment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Community Medicine, Mercer University School of Medicine, Columbus, Georgia, 31901, USA.
- Georgetown University, Data Science and Analytics Washington, DC 20057, USA.
- Germantown Medical Health Center, Germantown, Maryland, 20876 USA.
ORCID-Profile: Abraham M Enyeji
Zitieren
APA
Enyeji, A. M., Arora, A., & Mangat, H. S. (2024). Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports. Viral Immunology. https://doi.org/10.1089/vim.2024.0034
Vancouver
Enyeji AM, Arora A, Mangat HS. Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports. Viral Immunology. 2024. doi:10.1089/vim.2024.0034
BibTeX
@article{Enyeji2024,
author = {Enyeji, Abraham M and Arora, Amit and Mangat, Harpal S},
title = {Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports},
journal = {Viral Immunology},
year = {2024},
doi = {10.1089/vim.2024.0034}
}
EUVIMED